Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis

Boonphiphop Boonpheng, Charat Thongprayoon, Karn Wijarnpreecha, Juan Medaura, Fouad Chebib, Wisit Cheungpasitporn

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Complications related to peritoneal dialysis (PD) in patients with autosomal-dominant polycystic kidney disease (ADPKD), including intraperitoneal rupture of renal cyst, hernia, membrane failure and peritonitis, have been reported. However, long-term clinical outcomes of ADPKD patients on PD remain unclear. We performed this meta-analysis to assess the risks of death, technique failure and peritonitis in ADPKD patients on PD. Methods: A systematic review was conducted using MEDLINE, EMBASE and Cochrane databases from inception to October 2017 to identify studies that evaluated the outcomes of ADPKD patients on PD, including the risks of death, technique failure and peritonitis. Non-ADPKD patients on PD were used as controls. Effect estimates from the individual study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: Twelve cohort studies with a total of 14 673 patients on PD (931 ADPKD and 13 742 non-ADPKD patients) were enrolled. Compared with non-ADPKD status, ADPKD was associated with significantly decreased mortality risk with pooled odds ratio (OR) of 0.68 (95% confidence interval (CI), 0.53–0.86; I 2 = 0). There were no associations of ADPKD with the risks of technique failure of PD and peritonitis with pooled OR of 0.93 (95% CI, 0.79–1.10; I 2 = 0) and 0.88 (95% CI, 0.75–1.05; I 2 = 0), respectively. We found no publication bias as assessed by Egger's regression asymmetry test, with P = 0.90, 0.28 and 0.60 for the risks of mortality, technique failure and peritonitis in ADPKD patients on PD, respectively. Conclusion: Compared with non-ADPKD patients on PD, our study demonstrates that ADPKD patients on PD have 0.68-fold decreased mortality risk. There are no associations of ADPKD status with the risks of technique failure or peritonitis.

Original languageEnglish (US)
Pages (from-to)638-646
Number of pages9
JournalNephrology
Volume24
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Autosomal Dominant Polycystic Kidney
Peritoneal Dialysis
Meta-Analysis
Peritonitis
Polycystic Kidney Diseases
Confidence Intervals
Mortality
Odds Ratio
Publication Bias
Hernia
MEDLINE
Cysts
Rupture
Cohort Studies
Outcome Assessment (Health Care)
Databases
Kidney

Keywords

  • ADPKD
  • autosomal-dominant polycystic kidney disease
  • end-stage renal disease
  • meta-analysis
  • mortality
  • peritoneal dialysis

ASJC Scopus subject areas

  • Nephrology

Cite this

Boonpheng, B., Thongprayoon, C., Wijarnpreecha, K., Medaura, J., Chebib, F., & Cheungpasitporn, W. (2019). Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis. Nephrology, 24(6), 638-646. https://doi.org/10.1111/nep.13431

Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis : A meta-analysis. / Boonpheng, Boonphiphop; Thongprayoon, Charat; Wijarnpreecha, Karn; Medaura, Juan; Chebib, Fouad; Cheungpasitporn, Wisit.

In: Nephrology, Vol. 24, No. 6, 01.06.2019, p. 638-646.

Research output: Contribution to journalArticle

Boonpheng, B, Thongprayoon, C, Wijarnpreecha, K, Medaura, J, Chebib, F & Cheungpasitporn, W 2019, 'Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis', Nephrology, vol. 24, no. 6, pp. 638-646. https://doi.org/10.1111/nep.13431
Boonpheng, Boonphiphop ; Thongprayoon, Charat ; Wijarnpreecha, Karn ; Medaura, Juan ; Chebib, Fouad ; Cheungpasitporn, Wisit. / Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis : A meta-analysis. In: Nephrology. 2019 ; Vol. 24, No. 6. pp. 638-646.
@article{b3d0418a01ce4b5a99bc3384fba69b3b,
title = "Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis",
abstract = "Background: Complications related to peritoneal dialysis (PD) in patients with autosomal-dominant polycystic kidney disease (ADPKD), including intraperitoneal rupture of renal cyst, hernia, membrane failure and peritonitis, have been reported. However, long-term clinical outcomes of ADPKD patients on PD remain unclear. We performed this meta-analysis to assess the risks of death, technique failure and peritonitis in ADPKD patients on PD. Methods: A systematic review was conducted using MEDLINE, EMBASE and Cochrane databases from inception to October 2017 to identify studies that evaluated the outcomes of ADPKD patients on PD, including the risks of death, technique failure and peritonitis. Non-ADPKD patients on PD were used as controls. Effect estimates from the individual study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: Twelve cohort studies with a total of 14 673 patients on PD (931 ADPKD and 13 742 non-ADPKD patients) were enrolled. Compared with non-ADPKD status, ADPKD was associated with significantly decreased mortality risk with pooled odds ratio (OR) of 0.68 (95{\%} confidence interval (CI), 0.53–0.86; I 2 = 0). There were no associations of ADPKD with the risks of technique failure of PD and peritonitis with pooled OR of 0.93 (95{\%} CI, 0.79–1.10; I 2 = 0) and 0.88 (95{\%} CI, 0.75–1.05; I 2 = 0), respectively. We found no publication bias as assessed by Egger's regression asymmetry test, with P = 0.90, 0.28 and 0.60 for the risks of mortality, technique failure and peritonitis in ADPKD patients on PD, respectively. Conclusion: Compared with non-ADPKD patients on PD, our study demonstrates that ADPKD patients on PD have 0.68-fold decreased mortality risk. There are no associations of ADPKD status with the risks of technique failure or peritonitis.",
keywords = "ADPKD, autosomal-dominant polycystic kidney disease, end-stage renal disease, meta-analysis, mortality, peritoneal dialysis",
author = "Boonphiphop Boonpheng and Charat Thongprayoon and Karn Wijarnpreecha and Juan Medaura and Fouad Chebib and Wisit Cheungpasitporn",
year = "2019",
month = "6",
day = "1",
doi = "10.1111/nep.13431",
language = "English (US)",
volume = "24",
pages = "638--646",
journal = "Nephrology",
issn = "1320-5358",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis

T2 - A meta-analysis

AU - Boonpheng, Boonphiphop

AU - Thongprayoon, Charat

AU - Wijarnpreecha, Karn

AU - Medaura, Juan

AU - Chebib, Fouad

AU - Cheungpasitporn, Wisit

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Background: Complications related to peritoneal dialysis (PD) in patients with autosomal-dominant polycystic kidney disease (ADPKD), including intraperitoneal rupture of renal cyst, hernia, membrane failure and peritonitis, have been reported. However, long-term clinical outcomes of ADPKD patients on PD remain unclear. We performed this meta-analysis to assess the risks of death, technique failure and peritonitis in ADPKD patients on PD. Methods: A systematic review was conducted using MEDLINE, EMBASE and Cochrane databases from inception to October 2017 to identify studies that evaluated the outcomes of ADPKD patients on PD, including the risks of death, technique failure and peritonitis. Non-ADPKD patients on PD were used as controls. Effect estimates from the individual study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: Twelve cohort studies with a total of 14 673 patients on PD (931 ADPKD and 13 742 non-ADPKD patients) were enrolled. Compared with non-ADPKD status, ADPKD was associated with significantly decreased mortality risk with pooled odds ratio (OR) of 0.68 (95% confidence interval (CI), 0.53–0.86; I 2 = 0). There were no associations of ADPKD with the risks of technique failure of PD and peritonitis with pooled OR of 0.93 (95% CI, 0.79–1.10; I 2 = 0) and 0.88 (95% CI, 0.75–1.05; I 2 = 0), respectively. We found no publication bias as assessed by Egger's regression asymmetry test, with P = 0.90, 0.28 and 0.60 for the risks of mortality, technique failure and peritonitis in ADPKD patients on PD, respectively. Conclusion: Compared with non-ADPKD patients on PD, our study demonstrates that ADPKD patients on PD have 0.68-fold decreased mortality risk. There are no associations of ADPKD status with the risks of technique failure or peritonitis.

AB - Background: Complications related to peritoneal dialysis (PD) in patients with autosomal-dominant polycystic kidney disease (ADPKD), including intraperitoneal rupture of renal cyst, hernia, membrane failure and peritonitis, have been reported. However, long-term clinical outcomes of ADPKD patients on PD remain unclear. We performed this meta-analysis to assess the risks of death, technique failure and peritonitis in ADPKD patients on PD. Methods: A systematic review was conducted using MEDLINE, EMBASE and Cochrane databases from inception to October 2017 to identify studies that evaluated the outcomes of ADPKD patients on PD, including the risks of death, technique failure and peritonitis. Non-ADPKD patients on PD were used as controls. Effect estimates from the individual study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: Twelve cohort studies with a total of 14 673 patients on PD (931 ADPKD and 13 742 non-ADPKD patients) were enrolled. Compared with non-ADPKD status, ADPKD was associated with significantly decreased mortality risk with pooled odds ratio (OR) of 0.68 (95% confidence interval (CI), 0.53–0.86; I 2 = 0). There were no associations of ADPKD with the risks of technique failure of PD and peritonitis with pooled OR of 0.93 (95% CI, 0.79–1.10; I 2 = 0) and 0.88 (95% CI, 0.75–1.05; I 2 = 0), respectively. We found no publication bias as assessed by Egger's regression asymmetry test, with P = 0.90, 0.28 and 0.60 for the risks of mortality, technique failure and peritonitis in ADPKD patients on PD, respectively. Conclusion: Compared with non-ADPKD patients on PD, our study demonstrates that ADPKD patients on PD have 0.68-fold decreased mortality risk. There are no associations of ADPKD status with the risks of technique failure or peritonitis.

KW - ADPKD

KW - autosomal-dominant polycystic kidney disease

KW - end-stage renal disease

KW - meta-analysis

KW - mortality

KW - peritoneal dialysis

UR - http://www.scopus.com/inward/record.url?scp=85064657522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064657522&partnerID=8YFLogxK

U2 - 10.1111/nep.13431

DO - 10.1111/nep.13431

M3 - Article

C2 - 29952039

AN - SCOPUS:85064657522

VL - 24

SP - 638

EP - 646

JO - Nephrology

JF - Nephrology

SN - 1320-5358

IS - 6

ER -